CA Stock MarketDetailed Quotes
HLS HLS Therapeutics Inc
- 3.840
- +0.130+3.50%
15min DelayMarket Closed Dec 20 16:00 ET
122.09MMarket Cap-4.12P/E (TTM)
3.840High3.710Low591Volume3.710Open3.710Pre Close2.23KTurnover5.48052wk High0.00%Turnover Ratio31.79MShares3.00052wk Low-0.933EPS TTM74.07MFloat Cap24.598Historical HighLossP/E (Static)19.29MShs Float0.043Historical Low-1.127EPS LYR3.50%Amplitude--Dividend TTM1.08P/B1Lot Size--Div YieldTTM
HLS Therapeutics Inc Key Stats
EPS
According to the latest financial report of HLS Therapeutics Inc, the latest earnings per share (TTM) for the company is -0.15. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about HLS Therapeutics Inc's free cash flow? The latest report shows it as 1.50M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of HLS Therapeutics Inc shows that the company's current ratio is 1.56, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of HLS Therapeutics Inc, the quick ratio is 1.17, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of HLS Therapeutics Inc? The latest ROE figure is -5.98%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of HLS Therapeutics Inc, the total asset return on investment (ROA) is -2.67%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check HLS Therapeutics Inc's latest financial report to see how their gross margin is doing - currently at 84.13%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of HLS Therapeutics Inc, the net profit margin is -34.39%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data